You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
| Chapter title |
Nilotinib
|
|---|---|
| Chapter number | 3 |
| Book title |
Small Molecules in Hematology
|
| Published in |
Recent results in cancer research Fortschritte der Krebsforschung Progrès dans les recherches sur le cancer, January 2018
|
| DOI | 10.1007/978-3-319-91439-8_3 |
| Pubmed ID | |
| Book ISBNs |
978-3-31-991438-1, 978-3-31-991439-8
|
| Authors |
Martin Gresse, Theo D. Kim, Philipp le Coutre, Gresse, Martin, Kim, Theo D., le Coutre, Philipp |
| Abstract |
With imatinib still being linked to the breakthrough in CML therapy and probably being the most prescribed drug, second-generation TKIs are increasingly gaining importance. Showing higher response rates while not leading to more adverse events, nilotinib has become an attractive option in the first-line treatment of chronic-phase chronic myeloid leukemia. By reaching deep and long-lasting molecular remissions, discontinuation of TKIs is becoming one of the central topics of future CML therapy. Stopping nilotinib seems safe and provides a stable remission in about half of the eligible patients, though long-term data are still missing. |
Mendeley readers
The data shown below were compiled from readership statistics for 87 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Czechia | 1 | 1% |
| Unknown | 86 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 12 | 14% |
| Student > Ph. D. Student | 11 | 13% |
| Other | 9 | 10% |
| Student > Master | 8 | 9% |
| Researcher | 7 | 8% |
| Other | 12 | 14% |
| Unknown | 28 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 25 | 29% |
| Biochemistry, Genetics and Molecular Biology | 8 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 8% |
| Agricultural and Biological Sciences | 5 | 6% |
| Nursing and Health Professions | 3 | 3% |
| Other | 8 | 9% |
| Unknown | 31 | 36% |